​Excellence in research and development of non-coding RNA DIAGnostics in ONcology

Project description: 

RNADIAGON is an academic-industrial consortium focused on research and development it the field of non-coding RNA diagnostics in oncology. This consortium enables development of personal skills and knowledge of early-stage and experienced researchers from 5 European academic centers through their (i) long-term stays at the US research center of excellence (MD Anderson Cancer Center, University of Texas, USA) and (ii) traineeships at the education center and manufacturing facilities of industrial partner (BioVendor, Inc.) developing certified (CE-IVD) diagnostics, who will work on the development of a new non-coding RNA diagnostic kit in colorectal cancer adopted here as a model project.​


Grant holder:

Prof. Ondřej Slabý, Ph.D. Prof. Ondřej Slabý, Ph.D. Research Group Leader
Phone: +420 54949 6876, +420 54949 1331
Email: ,
Office:


Photogallery



Read more

18. Feb. 2020

New Diagnostic Method Will Help with Early Detection of Colon Cancer

Masaryk University, in collaboration with the Masaryk Memorial Cancer Institute and BioVendor, signed a license agreement for a patented diagnostic…